Echocardiographic quantification of mitral apparatus morphology and dynamics in patients with dilated cardiomyopathy
- PMID: 38318649
- PMCID: PMC10846232
- DOI: 10.1177/03000605231209830
Echocardiographic quantification of mitral apparatus morphology and dynamics in patients with dilated cardiomyopathy
Abstract
Mitral regurgitation is among the most common valvular heart diseases. Mitral regurgitation in patients with dilated cardiomyopathy is a complex pathology involving annular dilatation, papillary muscle displacement, systolic leaflet tethering, and left ventricular remodeling. Quantification of mitral apparatus damage in these patients is essential for successful interventional and surgical therapy. Mitral regurgitation in the presence of dilated cardiomyopathy is classified as Carpentier type IIIB, with restricted leaflet mobility as a standard feature. Echocardiography allows accurate evaluation of the complex anatomy and function of the mitral apparatus. Updated guidelines recommend two-dimensional followed by systematic three-dimensional echocardiographic evaluation in patients with mitral regurgitation. New three-dimensional echocardiographic software packages provide many parameters that help identify the precise morphology and function of the various components of the mitral apparatus, helping to determine the etiology of mitral regurgitation and evaluate disease severity. This review provides the first point-by-point approach to the assessment of all old and new echocardiographic methods, from the simplest to the most complex, used to examine the components of the mitral valve apparatus in patients with dilated cardiomyopathy. Although these parameters are still under research, this information will be helpful for establishing therapeutic procedures in a disease with a poor prognosis.
Keywords: Functional mitral regurgitation; dilated cardiomyopathy; echocardiography; mitral valve apparatus component; narrative review; valvular heart disease.
Conflict of interest statement
Declaration of conflicting interestThe author declares that there is no conflict of interest.
Figures












References
-
- Japp AG, Gulati A, Cook SA, et al.. The Diagnosis and Evaluation of Dilated Cardiomyopathy. J Am Coll Cardiol 2016; 67: 2996–3010. - PubMed
-
- Nieminen MS, Harjola VP, Hochadel M, et al.. Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 2008; 10: 140–148. - PubMed
-
- Pinto YM, Elliott PM, Arbustini E, et al.. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur. Heart J 2016; 37: 1850–1858. - PubMed
-
- Merlo M, Pivetta A, Pinamonti B, et al.. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: Changing mortality over the last 30 years. Eur. J. Heart Fail 2014; 16: 317–324. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources